Principal Investigator

Robert Kridel, MD PhD

Robert is a Clinician-Scientist at the Princess Margaret Cancer Centre and an Assistant Professor in the Department of Medicine at the University of Toronto. He trained in medical oncology in Geneva, Switzerland, prior to moving to Vancouver where he obtained his PhD from the University of British Columbia and completed a lymphoma fellowship at the BC Cancer Agency. Robert’s research interests lie in the application of genomic approaches to lymphoma samples, aiming to better understand how genetic alterations contribute to prognosis, treatment resistance and tumour evolution.

Scientific Associate

Kit Tong, PhD

Kit is a Scientific Associate and Lab Manager in our lab. She obtained her Bachelor of Science Degree from the University of Saskatchewan, and her PhD from the University of Tsukuba in Japan. Kit has extensive experience with cell biology, animal models, molecular biology and biochemistry. She won several awards during her training and has first- or co-authored over 40 publications.

Staff Computational Biologist

Karin Isaev, MSc

Karin is a Staff Computational Biologist, having previously obtained her MSc degree from the University of Toronto. Karin is trained in biology and statistics and is passionate about applying bioinformatics to improve patient care.

Research Technician

Mehran Bakhtiari, MSc

Mehran is a Research Technician in our lab. He holds a MSc degree in Biological Sciences from Laurentian University. Mehran has extensive experience with managing large-scale projects, molecular biology and screening of primary tissue and serum samples. He oversees accrual, processing and inventory of primary patient samples in our lab.

Clinical Research Coordinator

Michael Hong, MSc

Michael is a Clinical Research Coordinator who facilitates consenting of patients for translational research studies and liaises with the pathology department for all tissue requests.

Post-doctoral fellows

Tracy Lackraj, PhD

Tracy came to us from Ryerson University, after very successful doctoral studies in microbiology. She first-authored several papers on the pathogenicity of diarrheagenic pathogens during her PhD. Tracy is currently applying her molecular biology skills to lymphoma.

Michael He, PhD

Michael has recently joined the lab after completing his PhD in Melbourne at the Peter Mac. He comes to us with great exertise in CRIPR-Cas9 screens that he is no applying to lymphoma.

Anjali Silva, PhD

Anjali obtained her PhD in bioinformatics, with a focus on developing model-based clustering techniques for biological data. Anjali is applying unsupervised classification techniques to dissect the molecular heterogeneity of lymphoma. The goal of her project is to identify biologically defined molecular subtypes that may open new avenues for tailoring therapy.


Jesse Joynt, BSc

Jesse has recently completed his BSc at Queen’s University in Kingston. His project aims to uncover novel epigenetic vulnerabilities identified from CRISPR-Cas9 screens.

Sharon Yoon, BSc

Sharon has joined the lab as our first MSc student after completing her Bachelor of Science from University of Toronto Scarborough. Sharon’s research focuses on the identification of rational combination treatments to overcome resistance in B-cell lymphoma.

Clinical Research Fellow

Ho-Young Yhim, MD

Ho-Young is a fully trained hematologist from South Korea. He is spending a year in Toronto and has joined the lab to learn about translational lymphoma research while continuing his studies to understand how FDG-PET scans allow to refine prognosis in lymphoma.